1. Product
Overview
1.1. Market
Definition
1.2. Scope
of the Market
1.2.1. Markets
Covered
1.2.2. Years
Considered for Study
1.2.3. Key
Market Segmentations
2. Research
Methodology
2.1. Objective
of the Study
2.2. Baseline
Methodology
2.3. Key
Industry Partners
2.4. Major
Association and Secondary Sources
2.5. Forecasting
Methodology
2.6. Data
Triangulation & Validation
2.7. Assumptions
and Limitations
3. Executive
Summary
3.1. Overview
of the Market
3.2. Overview
of Key Market Segmentations
3.3. Overview
of Key Market Players
3.4. Overview
of Key Regions/Countries
3.5. Overview
of Market Drivers, Challenges, and Trends
4. Voice
of Customer
5. Global
Radiopharmaceuticals Market Outlook
5.1. Market
Size & Forecast
5.1.1. By Value
5.2. Market
Share & Forecast
5.2.1. By
Type (Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals)
5.2.2. By Source
(Nuclear Reactors and Cyclotrons)
5.2.3. By End
User (Hospitals & Clinics, Diagnostics imaging centre, Others)
5.2.4. By
Company (2023)
5.2.5. By
Region
5.3. Market
Map
6. North
America Radiopharmaceuticals Market Outlook
6.1. Market
Size & Forecast
6.1.1. By Value
6.2. Market
Share & Forecast
6.2.1. By
Type
6.2.2. By
Source
6.2.3. By End
User
6.2.4. By
Country
6.3. North
America: Country Analysis
6.3.1. United
States Radiopharmaceuticals Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Type
6.3.1.2.2.
By Source
6.3.1.2.3.
By End User
6.3.2. Mexico
Radiopharmaceuticals Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Type
6.3.2.2.2.
By Source
6.3.2.2.3.
By End User
6.3.3. Canada
Radiopharmaceuticals Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Type
6.3.3.2.2.
By Source
6.3.3.2.3.
By End User
7. Europe
Radiopharmaceuticals Market Outlook
7.1. Market
Size & Forecast
7.1.1. By Value
7.2. Market
Share & Forecast
7.2.1. By
Type
7.2.2. By
Source
7.2.3. By End
User
7.2.4. By
Country
7.3. Europe:
Country Analysis
7.3.1. France
Radiopharmaceuticals Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Type
7.3.1.2.2.
By Source
7.3.1.2.3.
By End User
7.3.2. Germany
Radiopharmaceuticals Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Type
7.3.2.2.2.
By Source
7.3.2.2.3.
By End User
7.3.3. United
Kingdom Radiopharmaceuticals Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Type
7.3.3.2.2.
By Source
7.3.3.2.3.
By End User
7.3.4. Italy
Radiopharmaceuticals Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Type
7.3.4.2.2.
By Source
7.3.4.2.3.
By End User
7.3.5. Spain
Radiopharmaceuticals Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Type
7.3.5.2.2.
By Source
7.3.5.2.3.
By End User
8. Asia-Pacific
Radiopharmaceuticals Market Outlook
8.1. Market
Size & Forecast
8.1.1. By Value
8.2. Market
Share & Forecast
8.2.1. By
Type
8.2.2. By
Source
8.2.3. By End
User
8.2.4. By
Country
8.3. Asia-Pacific:
Country Analysis
8.3.1. China
Radiopharmaceuticals Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Type
8.3.1.2.2.
By Source
8.3.1.2.3.
By End User
8.3.2. India
Radiopharmaceuticals Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Type
8.3.2.2.2.
By Source
8.3.2.2.3.
By End User
8.3.3. South
Korea Radiopharmaceuticals Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Type
8.3.3.2.2.
By Source
8.3.3.2.3.
By End User
8.3.4. Japan
Radiopharmaceuticals Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Type
8.3.4.2.2.
By Source
8.3.4.2.3.
By End User
8.3.5. Australia
Radiopharmaceuticals Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Type
8.3.5.2.2.
By Source
8.3.5.2.3.
By End User
9. South
America Radiopharmaceuticals Market Outlook
9.1. Market
Size & Forecast
9.1.1. By Value
9.2. Market
Share & Forecast
9.2.1. By
Type
9.2.2. By
Source
9.2.3. By End
User
9.2.4. By
Country
9.3. South
America: Country Analysis
9.3.1. Brazil
Radiopharmaceuticals Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Type
9.3.1.2.2.
By Source
9.3.1.2.3.
By End User
9.3.2. Argentina
Radiopharmaceuticals Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Type
9.3.2.2.2.
By Source
9.3.2.2.3.
By End User
9.3.3. Colombia
Radiopharmaceuticals Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Type
9.3.3.2.2.
By Source
9.3.3.2.3.
By End User
10. Middle
East and Africa Radiopharmaceuticals Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By
Type
10.2.2. By
Source
10.2.3. By End
User
10.2.4. By
Country
10.3.
MEA: Country Analysis
10.3.1. South
Africa Radiopharmaceuticals Market Outlook
10.3.1.1. Market
Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market
Share & Forecast
10.3.1.2.1.
By Type
10.3.1.2.2.
By Source
10.3.1.2.3.
By End User
10.3.2. Saudi
Arabia Radiopharmaceuticals Market Outlook
10.3.2.1. Market
Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market
Share & Forecast
10.3.2.2.1.
By Type
10.3.2.2.2.
By Source
10.3.2.2.3.
By End User
10.3.3. UAE Radiopharmaceuticals
Market Outlook
10.3.3.1. Market
Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market
Share & Forecast
10.3.3.2.1.
By Type
10.3.3.2.2.
By Source
10.3.3.2.3.
By End User
11. Market
Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market
Trends & Developments
12.1.
Merger & Acquisition (If Any)
12.2.
Product Launches (If Any)
12.3.
Recent Developments
13. Porters
Five Forces Analysis
13.1.
Competition in the Industry
13.2.
Potential of New Entrants
13.3.
Power of Suppliers
13.4.
Power of Customers
13.5.
Threat of Substitute Products
14. Competitive
Landscape
14.1.
PharmaLogic Holdings LLC
14.1.1. Business
Overview
14.1.2. Company
Snapshot
14.1.3. Products
& Services
14.1.4. Financials
(As Reported)
14.1.5. Recent
Developments
14.1.6. Key
Personnel Details
14.1.7. SWOT Analysis
14.2.
Jubilant Radiopharma
14.3.
China Isotope & Radiation Corporation
14.4.
Siemens Healthineers AG
14.5.
SHINE Technologies, LLC
14.6.
Ion Beam Applications SA
14.7.
Global Medical Solutions
14.8.
BWX Technologies. Inc
14.9.
Coquí Radio Pharmaceuticals Corp.
14.10.
Evergreen Theragnostics, Inc.
15. Strategic
Recommendations
16. About
Us & Disclaimer